Why the Wesfarmers (ASX:WES) share price is wobbling today

Wesfarmers is copping heat from shareholders for its cheap offer on the pharmaceutical retailer.

| More on:
Woman with large rollers in her hair and using cosmetics looking frustrated down at the ends of her hair.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Wesfarmers Ltd (ASX: WES) share price is up and down today after the company's bid for Australian Pharmaceutical Industries Ltd (ASX: API) faces new pressure from shareholders.

At market open Wesfarmers shares surged to $58.61 before dipping down to $58.01. At the time of writing, the Wesfarmers share price is up 0.47% to $58.70.

Let's take a look in a little more detail.

New pressure from shareholders

Wesfarmers shareholders are concerned the offer for the pharmaceutical retailer and distributor is too low, and that it opens the gates for rival bids to surface.

Key stakeholders have been outspoken, advocating to lift the bid. They say the offer, "undervalued [Australian Pharmaceutical] and a counter offer was not impossible," according to yesterday's Australian Financial Review.

The news comes after 19.3% shareholder Washington H. Soul Pattinson and Co. Ltd (ASX: SOL) gave its seal of approval on the $1.38 per share offer.

Since Monday's announcement, the API share price skyrocketed almost 20%, reaching a high of $1.38 yesterday.

API is the owner of Priceline Pharmacy and Clear Skincare beauty clinics, both of which operate throughout Australia.

Wesfarmers values the company's assets at $687 million, excluding $135 million debt on its balance sheet.

As such, the $1.38 per share offer is close to API's current market price at the time of writing.

Speaking on the proposal on Monday, Wesfarmers managing director Rob Scott said:

If the proposal is successful, API would form the basis of a new healthcare division of Wesfarmers and a
base from which to invest and develop capabilities in the health and wellbeing sector.

The offer is still subject to due diligence, clearance from the ACCC, and board approval from API.

Wesfarmers share price snapshot

The Wesfarmers share price has posted a year-to-date return of ~16%, extending the previous 12 month's return of 27.68%.

These returns have outpaced the S&P/ASX 200 Index (ASX: XJO)'s return of ~11.7% since 1 January this year.

At the time of writing, Wesfarmers has a market capitalisation of $66.5 billion.

The author Zach Bristow has no positions in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Wesfarmers Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

A young man clasps his hand to his head with his eyes closed and a pained expression on his face as he clasps a laptop computer in front of him, seemingly learning of bad news or a poor investment.
Share Fallers

Why ASX, CBA, Iperionx, and Sayona Mining shares are dropping today

These shares aren't having a good session on Tuesday. But why?

Read more »

A man sits in a chair hunched over a laptop and covered head to toe in frozen icicles to represent Envirosuite's trading halt
Capital Raising

Why the Novonix share price is frozen today

Time to refill the cash tank before it runs out.

Read more »

Woman looking at a phone with stock market bars in the background.
Share Market News

Why did the rising ASX 200 just reverse course into the red?

US Republican President-Elect Donald Trump has announced new tariffs on goods from China, Canada, and Mexico.

Read more »

A man has a surprised and relieved expression on his face. as he raises his hands up to his face in response to the high fluctuations in the Galileo share price today
Broker Notes

This ASX All Ords stock is undervalued and could rocket 60%+

Bell Potter is tipping this share to deliver big returns for investors.

Read more »

High fashion look. glamor closeup portrait of beautiful sexy stylish Caucasian young woman model with bright makeup, with red lips, with perfect clean skin.
Broker Notes

2 ASX All Ords shares top brokers rate as a 'buy'

See what the latest is for these two names.

Read more »

A cool young man walking in a laneway holding a takeaway coffee in one hand and his phone in the other reacts with surprise as he reads the latest news on his mobile phone
Broker Notes

This ASX 200 share is one of 'the highest quality businesses on the ASX'

Let's see which stock analysts at Wilsons rate incredibly highly right now.

Read more »

Smiling man with phone in wheelchair watching stocks and trends on computer
Share Market News

5 things to watch on the ASX 200 on Tuesday

Another good session is expected for Aussie investors today. Here's what you need to know.

Read more »

A businessman hugs his computer and smiles.
Opinions

If I were 40, I'd buy these ASX shares in 2024 for the long term

These investments look very compelling to me as buy-and-hold investments.

Read more »